Ed Gemo

Ed Gemo is the Vice President and Chief Information Officer at Halozyme Therapeutics. Ed has over 25 years of experience in the biotech and pharmaceutical industries. Prior to joining Halozyme, Ed was a Biotech IT Strategy Consultant at Barbosa Consulting. In this role, they provided a full review and gap analysis of IT investments across all business functions for biotech companies. Ed also created multi-year technology investment roadmaps to help biotech companies scale, file for FDA approval, and successfully launch their products while maintaining compliance with GxP regulations.

Ed has also served as an Independent CIO Consultant and as the Vice President and Chief Information Officer at Halozyme Therapeutics, Inc. In these roles, they were responsible for developing and implementing IT strategies that aligned with business goals, overseeing the day-to-day operations of the IT department, and managing budgets and resources.

Ed has a proven track record of success in developing and implementing IT strategies that support the growth and success of biotech companies. Ed is a strategic thinker who can see the big picture and develop creative solutions to complex problems. Ed is an excellent communicator and leader who is able to build consensus among stakeholders. Ed is a trusted advisor who is committed to helping their clients achieve their goals.

Ed Gemo has a BS in Computer Science from Brooklyn College and an MBA in Information Systems from Pace University - Lubin School of Business.

Ed Gemo reports to Helen Torley , President & CEO. They are on a team with Harry J. Leonhardt - Senior Vice President, General Counsel and Corporate Secretary, Benjamin J. Hickey - Senior Vice President, Chief Commercial Officer, and Alison A. Armour - Senior Vice President, Research and Development.